Cancer Research UK, July 2019
- As part of Wave 2 of the ACE Programme, five projects across England tested the viability of the Multidisciplinary Diagnostic Centre (MDC) model as an approach to improving outcomes for patients presenting with non-specific but concerning symptoms. This article addresses the challenges associated with achieving a full and rigorous evaluation of MDC cost effectiveness, before describing some of the practical approaches employed at a project level to understand pathway cost.
